Journey Medical Corporation

Healthcare

NASDAQ:DERM · NASDAQ Capital Market

Market Cap $172.56M Beta 1.10 P/E (TTM) -18.1

$6.34 +1.12%

+$0.07 today

52W Low $4.31High $9.56

Vol 0.17M · Avg 0.27M

EPS (TTM)-$0.35

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-6.49%

Period High

$9.26

Period Low

$4.39

Latest

$6.34

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

OraSure Technologies, Inc.

NASDAQ:OSUR

$287.79M

Cartesian Therapeutics, Inc.

NASDAQ:RNAC

$279.42M

Fennec Pharmaceuticals Inc.

NASDAQ:FENC

$257.22M

Orchestra BioMed Holdings, Inc.

NASDAQ:OBIO

$245.51M

Inventiva S.A.

NASDAQ:IVA

$200.13M

MediWound Ltd.

NASDAQ:MDWD

$154.46M

Organigram Global Inc.

NASDAQ:OGI

$149.22M

Solana Company

NASDAQ:HSDT

$89.92M

Nyxoah S.A.

NASDAQ:NYXH

$55.05M

China SXT Pharmaceuticals, Inc.

SXTC

$1.99M

What is the latest DERM filing?

The latest filing shown is 10-Q dated May 13, 2026.

How many recent filings does DERM have?

Intrinsic Alpha currently shows 20 recent filings for DERM.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.